Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 15, 2007Clinical Cancer ResearchOpen Access

High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

SSStefanie SarantopoulosDuke UniversityKSKristen E. StevensonBoston UniversityHKHaesook T. KimDana-Farber Cancer Institute

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sarantopoulos et al. (2007) studied this question.

synapsesocial.com/papers/6a10d00ced67694fb09f79ebhttps://doi.org/10.1158/1078-0432.ccr-07-1290
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Inflammation Controls B Lymphopoiesis by Regulating Chemokine CXCL12 Expression2004 · 256 citations
  2. 2TACI-BLyS signaling via B-cell–dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo2005 · 40 citations
  3. 3Occurrence of autoantibodies in chronic graft vs. host disease after allogeneic stem cell transplantation2005 · 39 citations
  4. 4Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate1995 · 279 citations
  5. 5B Lymphocytes Participate in Cross-Presentation of Antigen following Gene Gun Vaccination2005 · 84 citations